From: A comprehensive survey of the mutagenic impact of common cancer cytotoxics
Treatment | n | SNV | Insertion | Deletion |
---|---|---|---|---|
Mean ± SD | Mean ± SD | Mean ± SD | ||
None (starting clone) | 1 | 0 | 0 | 0 |
Mock | 4 | 47 ± 20 | 4.5 ± 1.3 | 3.0 ± 0.8 |
Cisplatin | 3 | 812 ± 193 | 49.0 ± 15.0 | 83.0 ± 21.2 |
Cyclophosphamide | 3 | 254 ± 50 | 3.0 ± 1.7 | 5.0 ± 1.7 |
Hydroxyurea | 3 | 74 ± 9 | 4.7 ± 1.5 | 3.7 ± 1.2 |
Gemcitabine | 3 | 57 ± 31 | 2.3 ± 2.1 | 3.0 ± 1.7 |
5-fluorouracil | 3 | 50 ± 16 | 3.0 ± 1.0 | 2.7 ± 1.5 |
Etoposide | 3 | 95 ± 15 | 3.7 ± 1.2 | 6.7 ± 4.2 |
Doxorubicin | 3 | 44 ± 15 | 3.3 ± 0.6 | 4.0 ± 4.6 |
Paclitaxel | 3 | 64 ± 10 | 1.0 ± 1.0 | 3.0 ± 0.0 |